A Culturally Tailored Scalable Asthma Intervention for Hispanic Children

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 12
Healthy Volunteers: f
View:

• Provision of signed and dated informed consent forms.

• Who has a child who is 5-12 years of age

• Whose child meets criteria for current persistent asthma defined as either:

‣ On a long-term controller medication for asthma, or

⁃ Meet NAEPP guideline requirements for persistent disease:)(35)

• Asthma symptoms 3 or more days per week over the past 2 weeks OR

∙ Nocturnal asthma symptoms at least 3 times in the past month

• Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months

• Parent/Caregiver identifies as Mexican American or other Hispanic descent

• Whose child has clinician diagnosed asthma

• Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access)

• Whose child is not currently participating in another asthma study.

⁃ The parent/caregiver is the primary study participant, but the child will be asked to complete some surveys at baseline and six months, so an assent will be obtained from the child.

Locations
United States
Texas
University of Texas at Austin
RECRUITING
Austin
Contact Information
Primary
Susan Balcer Whaley, MPH
susan.balcerwhaley@austin.utexas.edu
443-824-6107
Backup
Christian Vallejo, MS
christian.vallejo@austin.utexas.edu
512-658-5877
Time Frame
Start Date: 2024-03-22
Estimated Completion Date: 2025-05-01
Participants
Target number of participants: 50
Treatments
Active_comparator: Access to Asma Guardian website/app
Participants who are randomized to the Asma Guardian website at their baseline visit will have access to the website for 6 months starting at baseline. Access will be turned off at 6 months.
Other: No Access to Asma Guardian website/app for 6 months
Note: Participants who are randomized to no access will not receive access during the 6 months of the study; however they will receive 1 month of access after their 6 month study visit but any information gained during this time will not be part of analysis.
Related Therapeutic Areas
Sponsors
Leads: University of Texas at Austin
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov